Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

MEXC Upgrades 0-Fee Spot Trading to Cover All Pairs

December 22, 2025

Bitget Wallet and Alchemy Pay Launch Zero-Fee USDC On-Ramp Backed by Coinbase

December 22, 2025

Bitcoin Munari Presale Gains Focus as Investors Assess Early-Stage Exposure

December 22, 2025

MEXC Partners with ether.fi to Launch the Enhanced Payment Card with Up to 4% Cashback

December 22, 2025

Ambarella Accelerates Edge AI Innovation for Next Generation of Drones; Antigravity Deploys Ambarella’s CV5 AI SoC in Antigravity A1 Drone

December 22, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030
Press Release

Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030

By News RoomDecember 8, 20233 Mins Read
Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030
Share
Facebook Twitter LinkedIn Pinterest Email
Pharmaceutical Grade Lactose Market Predicted to Reach USD 2.81 Billion by 2030

Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) — The “Pharmaceutical Grade Lactose Market Size, Share & Trends Analysis Report By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, Spray Dried Lactose), By Region, And Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical grade lactose market size is expected to reach USD 2.81 billion by 2030, as per the new report by the publisher. The market is expected to expand at a CAGR of 5.4% from 2023 to 2030. This is attributable to the growing demand for novel medicines across the globe. Novel medicines, also known as new or innovative medicines, refer to pharmaceutical products that are newly developed and differ significantly from existing medications. These medicines often involve breakthrough discoveries or advancements in medical science and technology. Novel medicines may include biologics, new chemical entities (NCE), targeted therapies, gene therapies, and immunotherapies. The development of such novel medicines and drugs is driven by a high level of R&D activities being carried out by various drug manufacturing companies around the world.

Additionally, pharmaceutical formulations often require various excipients and manufacturers have a range of options to choose from alternative excipients that offer similar functionality and cost advantages may compete with the product, reducing its market demand. For example, according to JRS PHARMA, EMDEX shows great potential as a viable alternative to spray-dried lactose, as it exhibits comparable characteristics in terms of powder and tableting properties.

The pharmaceutical-grade lactose industry is characterized by intense competition, with multiple companies vying for market share and supplying the product to a wide range of end-users globally. To achieve a competitive edge, it is essential to focus on product launches, expansion, and research and development initiatives. As a result, leading manufacturers operational in the market strive to obtain high level of dominance by undertaking numerous initiatives.

Pharmaceutical Grade Lactose Market Report Highlights

  • The spray dried lactose segment emerged as the fastest growing application segment with a CAGR of 6.0% from 2023 to 2030, due to its ability to enhance the solubility and bioavailability of various pharmaceutical compounds
  • North America emerged as the fastest growing region with a CAGR of 5.8% from 2023 to 2030, the advancing end-use industry, coupled with research & development activities in key countries such as the U.S. and Canada, is anticipated to drive the demand for the product in the region over the forecast period
  • MEGGLE GmbH & Co. KG expanded its distribution network through agreements with exclusive distributors. For instance, it partnered with Barentz for the distribution of its pharmaceutical grade lactose in the U.S. These strategic initiatives are anticipated to collectively enable the company to continue playing a major role in the market
  • Kerry Ingredients India Private Limited and Lactose (India) Limited mutually agreed to terminate their contract for lactose co-manufacturing professionally and amicably. This decision was made in alignment with the strategic goals of both companies to focus on their respective core competencies while continuing to foster a positive and collaborative relationship for future opportunities

Key Attributes:

Report Attribute Details
No. of Pages 142
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $1.84 Billion
Forecasted Market Value (USD) by 2030 $2.81 Billion
Compound Annual Growth Rate 5.4%
Regions Covered Global

Companies Mentioned

  • ARMOR PROTEINES
  • BASF Corporation
  • Charotar Casein Company
  • DFE Pharma
  • Fengchen Group Co., Ltd
  • Kaserei Champignon Hofmeister GmbH & Co. KG
  • Kavya Pharma
  • Kerry
  • Lactalis Ingredients
  • Lactose (India) Limited
  • MEGGLE GmbH & Co. KG
  • Royal FrieslandCampina
  • Surfachem Group Ltd

For more information about this report visit https://www.researchandmarkets.com/r/st18iq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Pharmaceutical Grade Lactose Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

MEXC Upgrades 0-Fee Spot Trading to Cover All Pairs

Bitget Wallet and Alchemy Pay Launch Zero-Fee USDC On-Ramp Backed by Coinbase

Bitcoin Munari Presale Gains Focus as Investors Assess Early-Stage Exposure

MEXC Partners with ether.fi to Launch the Enhanced Payment Card with Up to 4% Cashback

Ambarella Accelerates Edge AI Innovation for Next Generation of Drones; Antigravity Deploys Ambarella’s CV5 AI SoC in Antigravity A1 Drone

CoinEx’s 2025 Annual Report: No More 4-Year Cycle – Navigating the Institution-Dominated Crypto Era

South Korea’s Jeju (CJU)-Seoul Gimpo (GMP) is the World’s Busiest Airline Route in 2025, Latest OAG Data Reveals

Payop unveils new player-first positioning and visual identity

CoinEx Reinforces Safety and Trust Through Proof of Reserve in December 2025

Editors Picks

Bitget Wallet and Alchemy Pay Launch Zero-Fee USDC On-Ramp Backed by Coinbase

December 22, 2025

Bitcoin Munari Presale Gains Focus as Investors Assess Early-Stage Exposure

December 22, 2025

MEXC Partners with ether.fi to Launch the Enhanced Payment Card with Up to 4% Cashback

December 22, 2025

Ambarella Accelerates Edge AI Innovation for Next Generation of Drones; Antigravity Deploys Ambarella’s CV5 AI SoC in Antigravity A1 Drone

December 22, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

CoinEx’s 2025 Annual Report: No More 4-Year Cycle – Navigating the Institution-Dominated Crypto Era

December 22, 2025

South Korea’s Jeju (CJU)-Seoul Gimpo (GMP) is the World’s Busiest Airline Route in 2025, Latest OAG Data Reveals

December 22, 2025

Payop unveils new player-first positioning and visual identity

December 22, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version